NYLI Global Equity R&D Leaders ETF (WRND)
| Assets | $10.38M |
| Expense Ratio | 0.18% |
| PE Ratio | 29.42 |
| Shares Out | 250,000 |
| Dividend (ttm) | $0.39 |
| Dividend Yield | 0.93% |
| Ex-Dividend Date | Jun 30, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | 27.31% |
| Volume | 64 |
| Open | 41.64 |
| Previous Close | 41.73 |
| Day's Range | 41.64 - 41.64 |
| 52-Week Low | 32.49 |
| 52-Week High | 43.75 |
| Beta | 1.02 |
| Holdings | 209 |
| Inception Date | Feb 8, 2022 |
About WRND
Fund Home PageThe NYLI Global Equity R&D Leaders ETF (WRND) is an exchange-traded fund that is based on the NYLI Global Equity R&D Leaders index. The fund tracks an index that seeks to provide exposure to global large- and mid-cap companies that have high research and development spending, and attractive future growth potential. WRND was launched on Feb 8, 2022 and is issued by New York Life Investments.
Top 10 Holdings
48.59% of assets| Name | Symbol | Weight |
|---|---|---|
| Alphabet Inc. | GOOGL | 7.22% |
| NVIDIA Corporation | NVDA | 7.10% |
| Apple Inc. | AAPL | 6.80% |
| ASML Holding N.V. | ASML | 5.20% |
| Taiwan Semiconductor Manufacturing Company Limited | 2330 | 4.97% |
| Microsoft Corporation | MSFT | 4.10% |
| Amazon.com, Inc. | AMZN | 4.10% |
| Broadcom Inc. | AVGO | 3.24% |
| Meta Platforms, Inc. | META | 3.08% |
| Eli Lilly and Company | LLY | 2.77% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 30, 2026 | $0.13909 | Jul 2, 2026 |
| Mar 31, 2026 | $0.05105 | Apr 2, 2026 |
| Dec 30, 2025 | $0.10597 | Jan 5, 2026 |
| Sep 30, 2025 | $0.09039 | Oct 6, 2025 |
| Jun 30, 2025 | $0.17666 | Jul 7, 2025 |
| Mar 31, 2025 | $0.10552 | Apr 4, 2025 |
Performance
WRND had a total return of 29.49% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.07%.
News
IndexIQ To Transfer Exchange Listing of Leaders in Research & Development ETF Suite To Nasdaq
NEW YORK--(BUSINESS WIRE)--IndexIQ today announced plans to transfer listing of the Leaders in Research & Development ETF Suite from NYSE Arca to Nasdaq.
IndexIQ Introduces ETF Suite Focused on Leaders in Research & Development
NEW YORK--(BUSINESS WIRE)--New IndexIQ ETFs are designed to provide exposure to companies positioned for future innovation and expansion through sustained investment in R&D.